期刊文献+

^(125)Ⅰ粒子植入治疗荷人肝癌裸鼠移植瘤的实验研究 被引量:12

The experimental study of ^(125)Ⅰ seed brachytherapy in human hepatocellular carcinoma bearing nude mice
在线阅读 下载PDF
导出
摘要 目的探讨^(125)Ⅰ粒子植入对荷人肝癌裸鼠移植瘤生长和细胞增殖及凋亡相关蛋白的影响。方法建立12只荷人肝癌 BEL-7402裸鼠模型,治疗组和对照组各6只。治疗组每只裸鼠移植瘤内植入1枚活度为33.3 MBq 的^(125)Ⅰ粒子,对照组不进行干预。治疗后每3~4 d 测量1次肿瘤直径,并计算治疗组肿瘤的体积抑制率。21 d 后处死卡果鼠,制作肿瘤组织标本,进行常规病理学检查和免疫组织化学检测增殖细胞核抗原(PCNA)、bcl-2和 bax 的表达。结果 ^(125)Ⅰ粒子治疗组肿瘤体积最大抑制率为49.2%,病理检查显示近粒子处肿瘤细胞变性坏死,远离粒子处可见存活肿瘤细胞。免疫组织化学显示治疗组 PCNA 表达强度和 bcl-2/bax 比值均低于对照组。结论 ^(125)Ⅰ粒子植入低剂量持续照射可直接杀死荷瘤鼠肝癌细胞或抑制肿瘤生长。 Objective To explore ihe-effect and-i-nfl-ue-nce of tumor growth, cell proliferation and apoptosis related protein of ^125I seed brachytherapy in human hepatocellular carcinoma( HHC ) bearing nude mice. Methods Twelve HHC BEL-7402 cells bearing nude mice were equally divided into treated and control group. One ^125I seed with 33.3 MBq was implanted into each mouse in treated group. Afterward the dimensions of tumor in both groups were measured every 3 ~ 4 d and also the tumor volume inhibition rates were calculated. Twenty-one days later, nude mice sacrificed and routine pathological examination proceeded. The expression of proliferating cell nuclear antigen (PCNA), bcl-2 and bax were detected by immunohistochemical methods. Results The maximum tumor inhibition rate of treated group was 49.2%. Routine pathological examination found degenerative necrosis at the site was nearby the seed but the alive tumor cell still presented faraway from the seed. The expression of PCNA and the ratio of bol-2/bax in treated group were lower than those in control group. Conchmion The sustained irradiation of ^125I seed brachytherapy can direct kill the HHC cell in nude mice or inhibit the proliferation of tumor cells.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2006年第1期23-25,共3页 Chinese Journal of Nuclear Medicine
关键词 肝肿瘤 肿瘤细胞 培养的 碘放射性同位素 近距离放射疗法 小鼠 Liver neoplams Tumor cells, cultured Iodine radioisotopes Brachytherapy Mice, nude
  • 相关文献

参考文献6

二级参考文献22

  • 1方永鑫,张海鹰,余征,袁玫,林星石,费丽华,李力,李华,田嘉禾,黄靖香,檀华,蒋彦永.放射性碘标记CL-3体外肿瘤细胞结合及瘤内注射动物实验研究[J].中华核医学杂志,1996,16(1):36-38. 被引量:3
  • 2Williamson JF, Coursey BM, Dewerd LA, et al. Guidence to users of Nycomed Amersham and North American Scientific, lnc, 1-125 interstitial sources: dosimetry and calibration changes: recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-energy Seed Dosimetry. Med Phys. 1999,26 : 570-573.
  • 3Chen Y, Stanton RE, Hoist R J, et al. Treatment planning for prostate implant with loose seeds. Med Phys, 1997,24 : 1141-1145.
  • 4Kim JH, Hilaris BS. Iodine-125 source in interstitial tumor therapy. Radiology, 1975,123 : 163-169.
  • 5Grimm PD, Blasko JC, Sylvester JE, et al. lO-year biochemical (prostate specific antigen) control of prostate cancer with ^125l brachylherapy, Int J Radiat Oncol Biol Phys,2001,51 :31-40.
  • 6Ragde H, Korb LJ, Elgamal AA, et al. Modem prostate brachytherapy: postate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer, 2000,89 : 135-141.
  • 7Ragde H, Grado GL, Nadir BS. Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone. Arch Esp Urol, 2001,54 : 739-747.
  • 8Chen A, Galloway M, Landreneau R, et al. lntraoperative 1-125 brachytherapy for high-risk stage 1 non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys, 1999,44: 1057-1063.
  • 9Martinez-Monge R, Nag S, Nierods CA, et al. Iodine-125 braehytherapy in the treatment of colorectal adenocarcinoma metastic to the liver. Cancer, 1999,85: 1218-1225.
  • 10Monk B J, Tewari KS, Puthawala AA, et al. Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation. Int J Radiat Oncol Biol Phys,2002,52:806-815.

共引文献155

同被引文献120

引证文献12

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部